D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and ...

Macular degeneration, particularly age-related macular degeneration (AMD), is a leading cause of vision loss worldwide. This ...

Types of wet AMD treatments. The main treatment involves eye injections of anti-VEGF drugs to stop problematic blood vessel growth. Options include aflibercept, bevacizumab, brolucizumab ...

Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal ...

A doctor will likely want to start anti-VEGF injections to help minimize macular damage. While wet AMD can physically impact daily life, research suggests that it can also affect emotional well ...

New treatments for macular degeneration may help preserve your eyesight for longer, without the need for frequent injections. Some of these treatments include retinal gene therapy and the "port ...

Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety ...

For wet AMD, you can slow or stop symptoms and possibly reverse vision changes with anti-VEGF injections. Find out how wet AMD can affect vision loss and your eye health. AMD is a common age ...

Participants in the trial will be administered two intravitreal injections of ... Tumstatin serves as an anti-inflammatory and anti-vascular endothelial growth factor (VEGF) agent by targeting ...